Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis

J Jiwon Oh (St. Michael’s Hospital, University of Toronto, Toronto) D Douglas L. Arnold (McGill University, Montreal) B Bruce A.C. Cree (Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco) C Carolina Ionete (Department of Neurology, UMass Chan Medical School, Worcester, MA) H Ho Jin Kim M Maria Pia Sormani S Sana Syed (Sanofi, Cambridge, MA) Y Yixin Chen C Christina R. Maxwell (Sanofi, Cambridge, MA) P Patrick Benoit (Sanofi, Chilly-Mazarin, France) T Timothy J. Turner (Sanofi, Cambridge, MA) E Erik Wallstroem (Sanofi, Cambridge, MA) H Heinz Wiendl (Institute for Neurology and Neurophysiology, Faculty of Medicine, University of Freiburg)

Article Details

Volume / Issue Vol. 392, Issue 19
Published May 15, 2025
Pages 1893-1904
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (13)

J

Jiwon Oh

St. Michael’s Hospital, University of Toronto, Toronto

D

Douglas L. Arnold

McGill University, Montreal

B

Bruce A.C. Cree

Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco

C

Carolina Ionete

Department of Neurology, UMass Chan Medical School, Worcester, MA

H

Ho Jin Kim

M

Maria Pia Sormani

S

Sana Syed

Sanofi, Cambridge, MA

Y

Yixin Chen

C

Christina R. Maxwell

Sanofi, Cambridge, MA

P

Patrick Benoit

Sanofi, Chilly-Mazarin, France

T

Timothy J. Turner

Sanofi, Cambridge, MA

E

Erik Wallstroem

Sanofi, Cambridge, MA

H

Heinz Wiendl

Institute for Neurology and Neurophysiology, Faculty of Medicine, University of Freiburg